Metall Zug AG (METN) AI Stock Analysis

• Market Cap: CHF448.27M
• Dividend Yield: 2%
• Average Volume (3M): 206.00
• Price to Earnings (P/E): 8.6
• Beta (1Y): 0.57
• Revenue Growth: -42.71%
• EPS Growth: N/A
• Country: CH
• Employees: 983
• Sector: Industrials
• Sector Strength: 87
• Industry: Conglomerates
• EPS (TTM): -6.60
• Shares Outstanding: 255,136
• 10 Day Avg. Volume: 285
• 30 Day Avg. Volume: 206
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF1,070.38
• Price Target Upside: 7.04% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: CHF1,082.00 ▲(8.20%Upside)

The overall stock score for Metall Zug AG is primarily impacted by its solid valuation metrics, which are offset by weak financial performance due to negative cash flow and declining revenue trends. Technical indicators suggest bearish momentum, reinforcing the need for cautious investment.

Metall Zug AG Business Overview & Revenue Model

Company Description

Metall Zug AG (METN) is a Swiss industrial holding company headquartered in Zug, Switzerland. The company operates through several divisions, including household appliances, infection control, wire processing, and medical devices. Metall Zug AG is known for its innovation and quality in providing advanced solutions and technologies in these sectors, aiming to enhance efficiency and reliability for its customers worldwide.

How the Company Makes Money

Metall Zug AG generates revenue through its diversified portfolio of businesses operating in distinct sectors. The household appliances division, primarily driven by its subsidiary V-ZUG, manufactures and sells premium kitchen and laundry appliances. The infection control division, led by Belimed, offers sterilization and disinfection solutions to healthcare facilities, ensuring high standards of hygiene and safety. The wire processing division, represented by Schleuniger, provides equipment and solutions for the wire and cable processing industry. Additionally, the medical devices division contributes to revenue by providing specialized medical technology solutions. The company's earnings are further supported by strategic partnerships, a focus on innovation, and a strong presence in global markets.

Metall Zug AG Financial Statement Overview

Summary

Metall Zug AG faces challenges in maintaining revenue growth and profitability while demonstrating strong balance sheet stability with low leverage. The negative cash flow trends pose risks to financial flexibility, necessitating improvements in cash-generating activities to support future operations.

Income Statement

The company has shown volatile revenue trends with a significant decline in recent years. Gross profit margin has been relatively stable but with a decreasing trend in total revenue. The net profit margin improved from previous losses, indicating better cost management, but overall profitability remains a challenge.

Balance Sheet

The company maintains a strong equity ratio and low debt levels, which enhances financial stability. However, the decrease in stockholders' equity and total assets over the years poses concerns about long-term asset management and growth potential.

Cash Flow

Free cash flow has been negative in recent years, indicating insufficient cash generation to support capital expenditures and other financial obligations. The operating cash flow has also declined, highlighting potential liquidity issues.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	283.42M	494.71M	645.94M	661.89M	823.54M
Gross Profit	90.95M	151.65M	226.69M	228.21M	261.41M
EBITDA	68.07M	43.12M	146.21M	57.62M	40.97M
Net Income	52.59M	22.22M	129.98M	48.78M	14.31M
Balance Sheet
Total Assets	632.95M	690.66M	701.19M	715.63M	635.24M
Cash, Cash Equivalents and Short-Term Investments	17.25M	29.80M	31.73M	81.84M	72.27M
Total Debt	82.81M	36.60M	17.00M	4.17M	4.65M
Total Liabilities	146.54M	168.84M	182.89M	199.44M	152.34M
Stockholders Equity	419.24M	455.51M	453.36M	450.94M	418.25M
Cash Flow
Free Cash Flow	-31.13M	-26.71M	-40.72M	14.27M	14.20M
Operating Cash Flow	2.77M	9.52M	-5.93M	48.98M	60.26M
Investing Cash Flow	-53.54M	-16.41M	-41.81M	-32.35M	-63.23M
Financing Cash Flow	37.44M	6.89M	-17.63M	-8.21M	-76.13M

Metall Zug AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1000.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:METN, the sentiment is Negative. The current price of 1000 is below the 20-day moving average (MA) of 1021.95, below the 50-day MA of 1036.18, and below the 200-day MA of 1065.55, indicating a bearish trend. The MACD of -8.14 indicates Positive momentum. The RSI at 39.94 is Neutral, neither overbought nor oversold. The STOCH value of 57.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:METN.

Metall Zug AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	71 Outperform	¥257.47B	14.37	8.45%	2.83%	6.40%	12.21%
KOMN	61 Neutral	CHF572.22M	99.21		2.84%	-16.31%	-107.34%
SWTQ	61 Neutral	CHF541.94M	91.85	0.83%	3.96%	-5.85%	-83.70%
METN	58 Neutral	CHF448.27M	8.56	11.76%	2.00%	-42.71%	―
VETN	54 Neutral	CHF596.70M	87.12		3.32%	-6.31%	-78.36%
RIEN	47 Neutral	CHF276.91M	30.04		3.15%	-28.40%	-117.97%
BYS	45 Neutral	CHF832.40M	―	-9.18%	0.99%	-30.30%	-261.35%

Metall Zug AG Corporate Events

Metall Zug AG Shareholders Approve Board Proposals and Sustainability Initiatives

At the 138th ordinary general meeting, Metall Zug AG’s shareholders approved all board proposals, including the election of Sandrine Zweifel to the board, a cash dividend distribution, and a contribution to the Greenhouse Gas Fund. These decisions align with the company’s strategic focus on sustainability and ophthalmology, potentially enhancing its industry positioning and stakeholder relations.